Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18 F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer - Bach-Gansmo, Tore; Nanni, Cristina; Nieh, Peter T; Zanoni, Lucia; Bogsrud, Tronde Velde; Sletten, Heidi; Korsan, Katrine Andersen; Kieboom, J; Tade, Funmilayo I; Odewole, Oluwaseun; Chau, Albert; Ward, Penelope; et al. (The Journal of urology, 2017)
Keywords: Adult; Aged; Aged, 80 and over; Carboxylic Acids; Cyclobutanes; emission-computed; fluciclovine F-18; Humans; local; Male; Middle Aged; neoplasm recurrence; Neoplasm Staging; Positron Emission Tomography Computed Tomography; positron-emission tomography; Predictive Value of Tests; Prostate-Specific Antigen - blood; prostatic neoplasms; Prostatic Neoplasms - blood; Prostatic Neoplasms - diagnostic imaging; Prostatic Neoplasms - pathology; Retrospective Studies; tomography; Urology; positive predictive value; positron-emission tomography; magnetic resonance imaging; MRI; detection rate; local; DR; emission-computed; ADT; FACBC; fluciclovine ( 18F); tomography; PPV; standard of truth; computerized tomography; PSA; androgen deprivation therapy; transrectal ultrasound; neoplasm recurrence; biochemical recurrence; flucovine F-18; BED-001; prostate specific antigen; BCR; CT; PSMA; prostate specific membrane antigen; prostatic neoplasms; Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC); SOT; TRUS; positron emission tomography; PET; fluciclovine F-18